Symbol="VKTX"
AssetType="Common Stock"
Name="Viking Therapeutics Inc"
Description="Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California."
CIK="1607678"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="12340 EL CAMINO REAL, SUITE 250, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1370296000"
EBITDA="None"
PERatio="None"
PEGRatio="-0.03"
BookValue="3.86"
DividendPerShare="0"
DividendYield="0"
EPS="-0.94"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.173"
ReturnOnEquityTTM="-0.269"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-0.94"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="33.8"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.865"
EVToRevenue="-"
EVToEBITDA="-2.068"
Beta="0.536"
num_52WeekHigh="25.72"
num_52WeekLow="2.535"
num_50DayMovingAverage="16.8"
num_200DayMovingAverage="13.2"
SharesOutstanding="99839000"
DividendDate="None"
ExDividendDate="None"
symbol="VKTX"
open="13.95"
high="14.29"
low="13.70"
price="13.98"
volume="1310755.00"
latest_trading_day="2023-08-18"
previous_close="14.14"
change="-0.16"
change_percent="-1.1315%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="38"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="3934261"
Change_recent_avg="-0.03"
Delta_recent_avg="1.21"
Variance_recent_avg="0.61"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="1095"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0128.jpeg"
image_negative_thumbnail_id_2="116"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0060.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="524"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0075.jpeg"
image_positive_thumbnail_id_1="1000"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0162.jpeg"
image_positive_thumbnail_id_2="971"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0133.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
